Article
Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma
2024-01-22
Abstract excerpt
Cisplatin resistance remains a significant barrier in treating lung adenocarcinoma (LUAD). While the search for predictive biomarkers in LUAD prognosis has seldom focused on cisplatin resistance genes. In this study, we analyzed 181 cisplatin resistance genes from LUAD-related cell lines RNA sequences data using the TCGA and GEO databases, identifying two pivotal genes, E2F7 and FAM83A. Utilizing these genes, we e...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 79de6d8e-1ee9-5b78-80cf-a17b47b02061
- DOI
- 10.21203/rs.3.rs-3877484/v1
